←Back to Expert Scholars
Translational Medicine / 转化医学Oligometastatic Disease
Matthias Guckenberger
MD
🏢University Hospital Zurich🌐Switzerland
Professor and Chair of Radiation Oncology
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Matthias Guckenberger has led the ESTRO EORTC consensus on the definition and characterization of oligometastatic disease, providing the field with a standardized classification. He has contributed to SBRT trials and radiomics research. His leadership organizes European oligometastatic research.
Share:
🧪Research Fields 研究领域
oligometastatic disease consensus
SBRT
ESTRO EORTC classification
lung SBRT
radiomics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Matthias Guckenberger 的研究动态
Follow Matthias Guckenberger's research updates
留下邮箱，当我们发布与 Matthias Guckenberger（University Hospital Zurich）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment